AMINEX THERAPEUTICS, INC.

Profile

Company Names

AMINEX THERAPEUTICS, INC.

Addresses

6830 NE BOTHELL WAY STE C139, KENMORE, WA 98028

6830 NE BOTHELL WAY, STE. C 139, KENMORE, WA 98028

6947 COAL CREEK PARKWAY SE, SUITE 364, NEWCASTLE, WA 98059

11335 NE 122ND, SUITE 105, KIRKLAND, WA 98034

Phone Numbers

512-413-8255
425-286-4222

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

WASHINGTON

Total Amount Raised:

$34,504,113.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2022-10-25 
$15,084,670.00 
$30,000,030.00 
$14,915,360.00 
Equity 
5
2021-08-04 
$6,298,504.00 
$9,141,549.00 
$2,843,045.00 
Equity 
4
2020-07-31 
$2,865,125.00 
$3,000,000.00 
$134,875.00 
Debt 
3
2018-05-17 
$8,253,117.00 
$14,166,867.00 
$5,913,750.00 
Equity 
2
2014-10-29 
$410,000.00 
$2,436,000.00 
$2,026,000.00 
Equity 
1
2014-06-26 
$1,592,697.00 
$1,750,000.00 
$157,303.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DEYAA 
 
ADIB 
DIRECTOR
MARK 
 
BURNS 
EXECUTIVE OFFICER, DIRECTOR
DON 
 
DYER 
DIRECTOR
THOMAS 
 
GRAHAM 
EXECUTIVE OFFICER, DIRECTOR
STACY 
 
HOCK 
DIRECTOR
DAVID 
 
MEEKS 
DIRECTOR
DONALD 
 
MOWAT 
DIRECTOR
LARRY 
 
RICHARDS 
EXECUTIVE OFFICER
JOHN 
 
ROSLING 
DIRECTOR
JAMES 
 
SKAGGS 
EXECUTIVE OFFICER, DIRECTOR
ROGER 
 
ULRICH 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-25 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-07-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-06-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#